story of the week
Significant Survival Benefit Conferred With Doublet Chemotherapy in Advanced NSCLC and ECOG PS 2
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non-Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2
J. Clin. Oncol 2013 Jun 17;[EPub Ahead of Print], M Zukin, CH Barrios, J Rodrigues Pereira, R De Albuquerque Ribeiro, CA de Mendonça Beato, YN do Nascimento, A Murad, FA Franke, M Precivale, LH de Lima Araujo, CS Da Rocha Baldotto, FM Vieira, IA Small, CG Ferreira, RC LilenbaumFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.